COVID-19 related deaths in an urban academic medical center in Brooklyn - a descriptive case series

James Andrew McCracken1, Mohamed Nakeshbandi1, Jeffrey Arace1

  • 1University Hospital of Brooklyn, SUNY Downstate Health Sciences University, 450 Clarkson Avenue, Box 36, Brooklyn, New York 11203 USA.

Insights

Black Americans with multiple comorbidities faced high COVID-19 mortality in Brooklyn. Elevated inflammatory markers and dyspnea at admission indicated increased risk for in-hospital death, highlighting healthcare disparities.

Area of Science:

  • Medical research
  • Public health
  • Epidemiology

Background:

  • Limited data exists on baseline demographics and hospital presentation of patients at risk of expiring from coronavirus disease 2019 (COVID-19), especially among Black American patients.
  • This study addresses the gap by examining similarities in demographics and hospital presentation among COVID-19 patients who died at an academic medical center in Brooklyn, New York.

Purpose of the Study:

  • To analyze the demographics and hospital presentation of patients who expired due to COVID-19.
  • To identify factors associated with increased risk of in-hospital mortality in COVID-19 patients, with a focus on the Black American population.

Main Methods:

  • Retrospective observational study of 200 patients with laboratory-confirmed SARS-CoV-2 infection who expired during hospital admission.
  • Data collection focused on patients who expired between March 17 and April 16, 2020, at an academic medical center in Brooklyn, New York.
  • Analysis included demographics, comorbidities, presenting symptoms, laboratory values (C-reactive protein, lactate dehydrogenase, ferritin), and time from symptom onset to expiration.

Main Results:

  • The study population was predominantly Black American (89%), with most patients having no history of international travel and multiple comorbidities (81%).
  • Common comorbidities included hypertension (84.5%), diabetes mellitus (57.5%), and obesity (41.5%). 55% had three or more comorbidities.
  • Elevated C-reactive protein, lactate dehydrogenase, and ferritin levels were observed on admission. Dyspnea was the most frequent symptom (92.5%), with a median of 8.42 days from symptom onset to expiration.

Conclusions:

  • Socioeconomic status and healthcare inequalities significantly impact the Black population, exacerbating COVID-19 infection outcomes in Brooklyn.
  • Patients presenting with multiple comorbidities and elevated inflammatory markers are at high risk for in-hospital mortality from COVID-19.
  • Findings underscore the need to address health disparities to mitigate severe outcomes in vulnerable populations.
Abstract

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.1K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
780
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
590
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
856
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
628
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K